ArticleAmerican journal of cancer research2016

Downregulation of GLUT4 contributes to effective intervention of estrogen receptor-negative/HER2-overexpressing early stage breast disease progression by lapatinib.

Sunil Acharya et al.PubMed ↗Full text ↗

No numbers read from the abstract.